Recerca

Genòmica Translacional

Buscador de publicacions

Publicacions

  • Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.

    Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination

    CANCER LETTERS . 380(1): 10-19. Nº de cites: 25

    [doi:10.1016/j.canlet.2016.06.012]

  • Hernandez-Muñoz I, Figuerola-Bou E, Sánchez-Molina S, Rodriguez E, Fernández-Mariño AI, Pardo-Pastor C, Bahamonde MI, Fernández-Fernández JM, García-Domínguez DJ, Hontecillas-Prieto L, Lavarino C, Carcaboso AM, de Torres C, Tirado OM, de Alava E and Mora J.

    RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-?B pathway, independently of the fusion oncoprotein

    Oncotarget . 7(29): 46283-46300. Nº de cites: 12

    [doi:10.18632/oncotarget.10092]

  • Rodriguez-Hernandez CJ, Mateo-Lozano S, Garcia-López M, Casalà C, Briansó F, Castrejon N, Rodriguez E, Suñol M, Carcaboso AM, Lavarino C, Mora J and de Torres C.

    Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens

    Oncotarget . 7(13): 16112-16129. Nº de cites: 17

    [doi:10.18632/oncotarget.7448]

  • Gomez-Gonzalez S, Castellano G, Mayol G, Queiros A, Martín-Subero JI and Lavarino C.

    DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights

    Genomics data . 5: 360-363. Nº de cites: 5

    [doi:10.1016/j.gdata.2015.07.016]

  • Monterrubio C, Paco-Mercader S, Vilà-Ubach M, Rodriguez E, Glisoni R, Lavarino C, Schaiquevich P, Sosnik A, Mora J and Carcaboso AM.

    Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts

    PHARMACEUTICAL RESEARCH . 32(9): 2889-2900. Nº de cites: 10

    [doi:10.1007/s11095-015-1671-9]

  • Mora J, Cruz-Martínez O, Lavarino C, Rios J, Vancells M, Parareda A, Salvador-Hernandez H, Suñol M, Carrasco-Torrents R, Guillen-Quesada A, Mañé S and de Torres C.

    Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7)

    CLINICAL & TRANSLATIONAL ONCOLOGY . 17(7): 521-529. Nº de cites: 12

    [doi:10.1007/s12094-014-1273-8]

  • Gomez-Gonzalez S, Castellano G, Mayol G, Suñol M, Queiros A, Bibikova M, Nazor KL, Loring JF, Lemos I, Rodríguez E, de Torres C, Mora J, Martín-Subero JI and Lavarino C.

    DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights

    EPIGENOMICS . 7(7): 1137-1153. Nº de cites: 36

    [doi:10.2217/epi.15.49]

  • Ottenhoff MJ, Mous SE, Castricum J, Rietman AB, Oostenbrink R, van der Vaart T, Tulen JHM, Parra-Checa A, Ramos F, Legius E, Moll HA, Elgersma Y and de Wit MY.

    Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo-controlled trial.

    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY . : . Nº de cites: 1

    [doi:10.1111/dmcn.16094]